Hochtief stock: CPB wins Queensland healthcare contract
Published on 11/21/2026 at 11:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQueensland contract adds healthcare focus
- CPB Contractors received the early contractor involvement contract on November 16.
- The Cairns project includes healthcare, education and research facilities.
- Main construction works are scheduled to begin in 2027.
Hochtief stock traded at 339.40 euros on Lang & Schwarz at 11:33 CET on Saturday, November 21. The company entered the weekend with a fresh infrastructure project in Australia after CIMIC Group company CPB Contractors received an early contractor involvement contract on November 16.
Queensland contract adds healthcare focus
According to MarketScreener, CPB Contractors is working with Hansen Yuncken on the Cairns Health Innovation & Surgical Centre for Health Infrastructure Queensland and the Cairns and Hinterland Hospital and Health Service. The early contractor involvement phase covers planning and preparation for a major healthcare, education and research facility in the Cairns Hospital precinct.
The planned scope also includes an option for a multi-storey car park and related precinct infrastructure, including a helipad and podium facilities. Early works are under way, while the main construction phase is scheduled to start in 2027.
Execution remains the next milestone
The award gives investors a further project milestone to track within CIMIC's Australian construction operations. The transition from early works to the main phase will be the next visible step, alongside any later disclosure on project scope, timing or commercial terms.
Hochtief company facts
- Company: Hochtief AG
- ISIN: DE0006070006
- Lang & Schwarz quote: 339.40 euros on Saturday, November 21, 2026, at 11:33 CET
- Xetra close: 355.60 euros on Thursday, November 19, 2026
- Sector: Construction and Engineering
Market context remains relevant for Hochtief stock; see current market reports.
For more company developments, visit More news and analyses on Hochtief stock.
